EcoDrugPlus

Adenosine Receptor A1-Like

Ensembl ID : ENSMAMG00000026371
Gene Symbol: LOC113129951
2 Cross references
144 Possible Orthologues:

Adenosine Receptor A3-Like

Ensembl ID : ENSMAMG00000026539
Gene Symbol: LOC113145536
2 Cross references
39 Possible Orthologues:

Adhesion Regulating Molecule 1

Ensembl ID : ENSMAMG00000007491
Gene Symbol: ADRM1
2 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 1aa

Ensembl ID : ENSMAMG00000008107
Gene Symbol: ADRA1AA
3 Cross references
202 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSMAMG00000008319
Gene Symbol: ADRA1B
2 Cross references
191 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSMAMG00000018587
Gene Symbol: ADRA1D
2 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSMAMG00000014596
Gene Symbol: ADRA2A
3 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSMAMG00000015149
Gene Symbol: ADRA2B
3 Cross references
174 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSMAMG00000007663
Gene Symbol: ADRA2C
3 Cross references
160 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSMAMG00000003890
Gene Symbol: ADRA2C
3 Cross references
157 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSMAMG00000015413
Gene Symbol: ADRB1
1 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSMAMG00000012468
Gene Symbol: ADRB2A
3 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).